Sam-A Pharm. Co. Ltd (009300) - Total Liabilities

Latest as of December 2025: ₩18.93 Billion KRW ≈ $12.83 Million USD

Based on the latest financial reports, Sam-A Pharm. Co. Ltd (009300) has total liabilities worth ₩18.93 Billion KRW (≈ $12.83 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sam-A Pharm. Co. Ltd - Total Liabilities Trend (2009–2025)

This chart illustrates how Sam-A Pharm. Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 009300 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Sam-A Pharm. Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Sam-A Pharm. Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
GCL Global Holdings Ltd Ordinary Shares NASDAQ:GCL	USA	$123.85 Million
Q.S.I Co. LTD KQ:066310	Korea	₩4.82 Billion
Korea Circuit Co Ltd KO:007815	Korea	₩601.95 Billion
Pharmx Technologies Ltd AU:PHX	Australia	AU$2.90 Million
Broad Capital Acquisition Corp NASDAQ:BRAC	USA	$13.30 Million
Aplisens SA WAR:APN	Poland	zł12.46 Million
Yandal Resources Ltd AU:YRL	Australia	AU$817.10K
Woosu AMS Co.Ltd KQ:066590	Korea	₩195.82 Billion

Liability Composition Analysis (2009–2025)

This chart breaks down Sam-A Pharm. Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 009300 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	9.78	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.08	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sam-A Pharm. Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sam-A Pharm. Co. Ltd (2009–2025)

The table below shows the annual total liabilities of Sam-A Pharm. Co. Ltd from 2009 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩18.93 Billion ≈ $12.83 Million	-34.16%
2024-12-31	₩28.76 Billion ≈ $19.49 Million	-6.74%
2023-12-31	₩30.84 Billion ≈ $20.90 Million	+36.57%
2022-12-31	₩22.58 Billion ≈ $15.30 Million	+31.68%
2021-12-31	₩17.15 Billion ≈ $11.62 Million	+8.39%
2020-12-31	₩15.82 Billion ≈ $10.72 Million	-30.10%
2019-12-31	₩22.63 Billion ≈ $15.34 Million	+77.05%
2018-12-31	₩12.78 Billion ≈ $8.66 Million	+7.76%
2017-12-31	₩11.86 Billion ≈ $8.04 Million	-11.19%
2016-12-31	₩13.36 Billion ≈ $9.05 Million	+4.11%
2015-12-31	₩12.83 Billion ≈ $8.69 Million	+9.53%
2014-12-31	₩11.71 Billion ≈ $7.94 Million	-50.08%
2012-12-31	₩23.46 Billion ≈ $15.90 Million	-14.00%
2011-12-31	₩27.28 Billion ≈ $18.49 Million	+1.94%
2010-12-31	₩26.76 Billion ≈ $18.14 Million	-14.17%
2009-12-31	₩31.18 Billion ≈ $21.13 Million	--

About Sam-A Pharm. Co. Ltd

KQ:009300 Korea Pharmaceuticals

Market Cap

$55.13 Million

₩81.36 Billion KRW

Market Cap Rank

#21578 Global

#1258 in Korea

Share Price

₩13330.00

Change (1 day)

-3.48%

52-Week Range

₩12910.00 - ₩19050.00

All Time High

₩36150.00